| PERIOD ENDING | 25-Sep-09 | 30-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 60,423 | 111,464 | 98,637 | 127,754 | | Cost of Revenue | 50,880 | 99,592 | 87,657 | 115,075 | | | Gross Profit | 9,543 | 11,872 | 10,980 | 12,679 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,678 | 8,102 | 7,318 | 8,895 | | Non Recurring | 686 |
-
|
-
| 21,438 | | Others | 1,950 | 3,366 | 2,466 | 2,733 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 229 | 404 | 1,196 | (20,387) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 229 | 404 | 1,196 | (20,387) | | Interest Expense | 264 | 519 | 673 | 846 | | Income Before Tax | (35) | (115) | 523 | (21,233) | | Income Tax Expense | 56 | 4,515 | 24 | (850) | | Minority Interest | 27 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (79) | (5,079) | 499 | (20,383) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (79) | (5,079) | 499 | (20,383) | | Preferred Stock And Other Adjustments | (834) | (215) |
-
|
-
| | | Net Income Applicable To Common Shares | ($913) | ($5,294) | $499 | ($20,383) |
|
0.03% Nasdaq 
Income Statement
